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Superior  vena  cava  syndrome  can  occur  from  benign  conditions  that  might  not  alter  life  expectancy.  Here  we 
present  a  case  of  a  superior  vena  cava  (SVC)  obstruction  caused  by  soft  tissue  encircling  the  SVC,  which  was  strongly 
suspected  of  being  an  unusual  focal  type  of  fibrosing  mediastinitis.  A  39-year-old  man  with  no  prior  medical  history 
presented  with  a  four-week  history  of  facial  plethora,  headache  and  dilated  veins  of  the  neck  with  a  dark  purple  color 
change  on  the  anterior  chest  wall.  Radiology  examinations,  including  venography,  and  computed  tomography  with  a 
3-dimensional  volume-rendering  image  of  the  chest,  had  revealed  severe  narrowing  of  the  SVC  due  to  tiny  encircling 
soft  tissue  and  collateral  vessels.  A  total  occlusion  of  the  SVC  occurred  as  a  result  of  a  thrombus  that  developed  within 
1  day  after  the  diagnostic  SVC  angiogram.  The  patient  underwent  stent  deployment  three  days  after  the  administration 
of  thrombolytic  therapy. 
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INTRODUCTION 
Superior  vena  cava  (SVC)  syndrome  is  associated  with 
anvanced  malignancy  and  has  a  poor  prognosis
1).  However,  a 
symptomatic  SVC  obstruction  can  also  be  caused  by  benign 
conditions  that  do  not  affect  the  life  expectancy  of  the  patient. 
Reported  cases  of  SVC  syndrome  from  benign  processes 
include  the  following:  infectious  diseases  such  as  tuberculosis, 
histoplasmosis,  and  a  pyogenic  infection;  fibrosing  processes 
either  idiopathic  or  following  radiation  therapy;  endovascular 
devices  such  as  transvenous  cardiac  devices  or  indwelling 
catheters;  vascular  anomalies,  aneurysms,  vasculitis  as  well  as 
a  number  of  other  rarer  etiologies
2).  Here  we  report  a  case  of 
SVC  syndrome  that  was  caused  by  soft  tissue  encircling  the 
SVC  with  thrombus  complications  along  with  the  accompanying 
CT  findings  using  a  3-dimensional  volume-rendering  technique.
CASE REPORT 
A  39-year-old  man  with  no  prior  medical  history  presented 
with  a  four-week  history  of  facial  plethora,  headache  and  dilated 
veins  of  the  neck  with  a  dark  purple  color  change  on  the 
anterior  chest  wall.  He  had  a  normal  chest  radiogram  and  a 
normal  blood  test.  Interestingly,  16-slice  multi-detector 
computed  tomography  (MDCT)  of  the  chest  and  a  3- 
dimensional  volume-rendering  image  revealed  a  severe 
narrowing  of  the  SVC  which  occurred  as  a  result  of  tiny 
encircling  soft  tissue  and  collateral  vessels  (Figure  1).  An  SVC 
angiogram  also  revealed  significant  luminal  narrowing  of  the 
SVC  (Figure  2). 
One  day  after  the  SVC  angiogram,  the  patient  complained  of 
severe  headache  and  facial  edema.  A  repeat  SVC  angiogram 
revealed  a  thrombus  at  the  right  brachiocephalic  vein  and  a 
total  occlusion  of  the  SVC  (Figure  3A).  A  bolus  of  urokinase Dae  Hyeok  Kim,  et  al  :  Superior  Vena  Cava  Syndrome 119
Figure 1. Contrast enhanced CT shows focal stenosis (arrow) of SVC caused by small encircling soft tissue 
and  a  collateral  vessel  (arrowhead)  (A).  A  three-dimensional  volume-  rendering  image  also  shows  focal 
stenosis  of  the  SVC  (arrow)  and  the  collateral  vessel  (arrowhead)  in  the  posterior  view  (B).
Figure  2.  SVC  angiogram  shows  focal  stenosis  of  the  SVC 
(arrow). 
500,000  IU  was  delivered  through  a  multipurpose  catheter.  The 
follow-up  SVC  angiogram  revealed  a  decrease  in  the  size  of 
the  thrombus  and  distal  venous  flow  to  right  atrium  (Figure  3B). 
Three  days  later,  another  follow-up  SVC  angiogram  revealed 
significant  luminal  narrowing  of  the  SVC  that  was  identical  to  the 
initial  findings  (Figure  4A).  A  14    60  mm  Cook  Zilver  stent  was 
deployed  in  the  SVC  (Figure  4B),  and  the  postprocedural  CT 
revealed  a  wide  patency  (Figure  5).  The  patient  was  discharged 
after  the  facial  plethora,  headache  and  color  change  on  the 
anterior  chest  wall  had  been  relieved. 
DISCUSSION
SVC  syndrome  was  first  described  by  Hunter  in  1757
3).  As 
reported  in  recent  reports,  73～93%  of  all  cases  of  SVC 
syndrome  have  resulted  from  either  a  primary  or  metastatic 
malignancy  with  the  remainder  of  the  cases  due  to  benign 
disease
4-6).  Many  benign  causes  have  been  described  including 
fibrosing  mediastinitis  and  iatrogenic  etiologies  such  as  sclerosis 
and  obstructions  that  are  caused  by  the  use  of  indwelling 
central  venous  catheters
2).  Approximately  half  of  the  benign 
cases  have  mediastinal  fibrosis
6).  However,  the  increase  in  the 
implementation  of  indwelling  central  venous  catheters  and 
permanent  pacemakers  has  resulted  in  more  patients  with  a 
superior  vena  cava  obstruction  with  a  benign  etiology
4). 
In  our  case,  the  CT  and  3-dimensional  volume-rendering 
image  showed  a  small  amount  of  soft  tissue  encircling  the  SVC. 
It  even  accurately  revealed  the  extent,  level,  length  of  stenosis, 
the  presence  of  collateral  vessels  and  could  confidently 
differentiate  other  infiltrative  lesions  of  the  mediastinum,  such  as 
a  lung  cancer,  a  metastatic  carcinoma,  a  lymphoma,  and  a 
mediastinal  sarcoma.  Although  the  focal  type  of  fibrosing 
mediastinitis  was  strongly  suspected,  there  was  no  calcified 
mass,  which  is  a  typical  finding.  Therefore,  fibrosing  mediastinitis 
could  not  be  confidently  differentiated  from  the  other  lesions  and 
a  biopsy  was  required.  However,  a  histological  examination 
could  not  be  carried  out  because  the  patient  refused  surgical 
sampling  and  there  was  a  significant  risk  of  hemorrhage  during 
the  biopsy.  In  one  unusual  case  report  of  localized  fibrosing 
mediastinitis,  CT  and  magnetic  resonance  (MR)  images  of  the 
chest  showed  an  intraluminal  mass  in  the  SVC  without 
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Figure 3. SVC angiogram shows a 3.7×1.2 cm sized thrombus at the right brachiocephalic vein (arrow) and 
a  total  occlusion  of  the  SVC  (A).  After  urokinase  infusion,  the  follow-up  SVC  angiogram  shows  a  smaller 
thrombus  (arrow)  and  distal  venous  flow  to  right  atrium  (B). 
Figure  4.  The  SVC  angiogram  shows  focal  stenosis  of  the  SVC  and  no  thrombus  (A).  A  post-stent  SVC 
angiogram  demonstrated  a  widely  patent  SVC  (arrow)(B).
calcification
7).  These  reported  images  were  similar  to  that  seen 
in  our  case  except  for  the  size  of  the  mass.  Fibrosing 
mediastinitis  is  a  rare  benign  disorder  caused  by  the 
proliferation  of  acelluar  collagen  and  fibrous  tissue  within  the 
mediastinum
7)  The  SVC  is  most  commonly  involved,  with  the 
fibrosing  mediastinitis  causing  SVC  syndrome
7).  The  precise 
pathogenesis  and  cause  is  unknown.  However,  many 
hypotheses  have  been  proposed  to  explain  this  process.  These 
explanations  include  an  immune  reaction,  chronic  inflammation, 
drugs,  familial  disorder,  malignancy  and  radiation
7).  There  are 
two  types  of  fibrosing  mediastinitis.  The  focal  type  usually 
manifests  on  CT  or  MR  images  as  a  localized,  calcified  mass 
in  the  paratracheal  or  subcarinal  lesions  of  the  mediastinum,  or 
in  the  pulmonary  hila
8).  The  diffuse  type  manifests  on  CT  or  MR 
images  as  a  diffusely  infiltrating,  often  noncalcified  mass,  that 
affects  multiple  mediastinal  compartments
8). 
It  was  remarkable  that  the  thrombosis  developed  abruptly 
and  a  total  occlusion  of  the  SVC  occurred  within  1  day  after  the 
diagnostic  SVC  angiogram  had  been  performed.  This  case  is 
believed  to  be  due  to  a  procedure-related  complication.  After 
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Figure  5.  A  post-stent  contrast  enhanced  CT  demonstrates  a  widely  patent  SVC  (arrow)  (A).  A 
three-dimensional volume-rendering image also shows a widely patent SVC (arrow) in the posterior view (B).
thrombolytic  therapy  for  3  days,  the  lesion  recovered  in  a  similar 
way  to  the  initial  lesion  and  a  stent  was  deployed. 
The  treatment  for  SVC  syndrome  must  be  tailored  to  the 
underlying  etiology  and  work  quickly  enough  to  relieve  its 
severity  or  prevent  life-threatening  conditions.  The  treatment  of 
a  SVC  obstruction  due  to  a  malignancy  includes  therapy  with 
diuretics,  steroids,  and  head  elevation  followed  by  chemotherapy 
or  radiation  therapy,  and  a  subsequent  endovascular  procedure 
with  angioplasty  and  stent  placement  for  palliative  purposes
9). 
Therapy  for  a  SVC  obstruction  due  to  benign  causes  should  still 
be  aimed  at  the  underlying  etiology.  Medical  therapy  with 
anticoagulation  agents  might  provide  some  relief  of  symptoms. 
However,  the  relief  of  symptoms  can  be  accomplished  by 
relieving  the  stenosis  if  medical  therapy  with  anticoagulation 
agents  alone  does  not  sufficiently  alleviative  the  symptoms  or 
there  is  a  stricture  or  stenosis  of  the  SVC.  Historically,  this  has 
been  accomplished  by  surgery.  However,  surgery  may  not  be 
tolerated  by  patients  with  unstable  conditions  and  often  fails 
because  of  a  thrombosis  of  the  surgically  created  graft
10).  It  was 
recently  reported  that  mid-term  patency  is  acceptable  in 
patients  undergoing  endovascular  stent  placement  in  cases  of 
benign  disease,  and  may  be  a  feasible  therapeutic  option
11).
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